Register Now

Book your Hotel Now

Contact Us


WFIRM's Alumni Reception
Date: Monday, December 4, 2017
Time: 6:00 PM-7:30 PM
Location: 213 CD in the Charlotte Convention Center
501 South College Street, Charlotte, NC 28202

Thematic Working Interest Groups (TWIGs)

Organizational Meetings Information

Plenary Speakers Announced

Dr. Samuel Stupp

Dr. George V. Ludwig

Dr. Kiran Masunuru

Important Dates:

Promotional Material:

Call for Abstracts Announcements: 4:3 | Widescreen


2017 Sponsors:


Burroughs Wellcome Fund


Wake Forest Institute for Regenerative Medicine (WFIRM)



McGowan Institute of Regenerative Medicine at the University of Pittsburgh (MIRM)

PeproTech, Inc.

Tissue Source, LLC

Business Plan Competition Sponsor

BioLife Solutions

Pre-Conference Workshop Sponsor - Imaging and Assessment of Engineered Tissues



O2M Technologies


2017 Exhibitors:

Advanced BioMatrix

Advanced Solutions Life Sciences


American Society of Transplantation

Aptus Bioreactors

Aspect Biosystems Ltd.

Biomomentum Inc.

BioSpherix Medical


CellScale Biomaterials Testing

Evonik Corporation

Flexcell International Corporation

The Geneva Foundation


International Institute for the Advancement of Medicine / IIAM

IOP Publishing

JPK Instruments AG

Kuraray Co. Ltd

LifeCore Biomedical

Mary Ann Liebert, Inc.

McGowan Institute for Regnerative Medicine at the Univeristy of Pittsburgh


Moor Instruments, Inc.

Nanoscience Instruments

NanoScribe GmbH

Nitta Gelatin

North Carolina Biotech Center

PeproTech Inc.

Perimed Inc.

Rees Scientific

Rheolution Inc.


SERVA Electrophoresis GmbH

STEMCELL Technologies Inc.

Tissue Source, LLC


University of Alberta / Banff Foundation for Allograft Pathology

Wake Forest Institute for Regenerative Medicine


Organized By:

TERMIS-AM Meeting is organized by the
Tissue Engineering & Regenerative Medicine International Society.

Planning Committee

We are pleased to announce the following chairs of our Planning Committee who are working together to create our conference program:

Anthony Atala, MD
Program Chair

Dr. Atala is the Director of the Institute for Regenerative Medicine, and Chair of Urology at Wake Forest University. He is Editor in Chief of Stem Cells Translational Medicine and BioPrinting.

Dr. Atala is a recipient of the US Congress funded Christopher Columbus Award, the World Technology Award in Medicine, the Samuel Gross Prize, the Innovation Award from the Society of Manufacturing Engineers, and the Edison Science/Medical Award. He was elected to the National Academy of Medicine in 2011, and to the National Academy of Inventors in 2014. His work was listed twice in Time Magazine’s top 10 medical breakthroughs of the year. He was named by Scientific American as one of the world’s most influential people in biotechnology in 2015.  He also received the Innovator of the Year Award from R & D Magazine in 2016.

Dr. Atala has led several NIH working groups and was the Founder of the Regenerative Medicine Foundation. He heads a team of over 450 researchers, and twelve applications of technologies developed in his laboratory have been used clinically. He is editor of 14 books, has published over 500 articles and has applied for or received over 250 national and international patents.

Shay Soker, PhD
Program Co-Chair

Professor of Regenerative Medicine, Biomedical Engineering, Cancer Biology and Surgical Research
Wake Forest Institute for Regenerative Medicine
Wake Forest School of Medicine, Winston‐Salem, North Carolina

Dr. Soker is a Professor of Regenerative Medicine at the Wake Forest Institute for Regenerative medicine and an affiliated Professor of Cancer Biology, Physiology & Pharmacology, Biomedical Engineering and Surgical Sciences. Dr. Soker received his Ph.D. from the Technion‐Israel Institute for Technology and was postdoctoral trainee in the Department of Surgical Research at the Children’s Hospital Boston and Harvard Medical School. Working with Michael Klagsbrum and the late Judah Folkman, Dr. Soker research focused on vascular biology, especially angiogenic growth factors and their receptors.

Dr. Soker Joined the Laboratory for Tissue Engineering and Cellular Therapies, under the leadership of Anthony Atala, and was promoted to Assistant Professor at the Harvard Medical School. In 2004, Dr. Soker and the group moved to Wake Forest to form the Wake Forest Institute for Regenerative Medicine. Dr. Soker was promoted to Associate Professor in 2004 and he is a tenured Professor since 2010. Dr. Soker has authored more than 130 scientific publications and reviews, and has written chapters in several books. Dr. Soker won numerous academic awards including research grants from NIH, US Army, foundations and industry. During his academic career he had mentored many graduate students and post‐doctoral trainees; all have moved on to pursue academic/medical careers. Dr. Soker is frequently invited to organize and chair national and international scientific meeting and conferences. Dr. Soker is a participant in many of TERMIS’ activities such as a session chair in meetings and a presenter and provides guidance to TERMIS’ young investigators. He had previously served on the TERMIS‐AM council and is the Program Chair of the TERMIS‐AM 2017.

James J. Yoo, MD, PhD
Scientific Co-Chair

Associate Director and Chief Scientific Officer
Wake Forest Institute for Regenerative Medicine
Wake Forest School of Medicine
Winston-Salem, North Carolina, U.S.A.

Dr. Yoo is a surgeon and researcher. He is currently a Professor, Associate Director and Chief Scientific Officer at the Wake Forest Institute for Regenerative Medicine, and is cross-appointed to the Departments of Physiology and Pharmacology and Biomedical Engineering. Dr. Yoo's research efforts have been directed toward the clinical translation of tissue engineering technologies and cell-based therapies. Dr. Yoo's background in cell biology and medicine has facilitated the transfer of several cell-based technologies from the bench-top to the bedside. A few notable examples of successful clinical translation include the bladder, urethra, vagina, and muscle cell therapy for incontinence. Dr. Yoo has been a lead scientist in the bioprinting program at WFIRM, and has been instrumental in developing skin bioprinting and integrated organ printing systems for preclinical and clinical applications.